208 related articles for article (PubMed ID: 27436268)
1. Stability-Indicating Method and LC-MS-MS Characterization of Forced Degradation Products of Sofosbuvir.
Nebsen M; Elzanfaly ES
J Chromatogr Sci; 2016 Oct; 54(9):1631-1640. PubMed ID: 27436268
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for the characterization of the forced degradation products of Entecavir.
Ramesh T; Rao PN; Rao RN
J Sep Sci; 2014 Feb; 37(4):368-75. PubMed ID: 24323372
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug.
Rao RN; Ramachandra B; Sravan B; Khalid S
J Pharm Biomed Anal; 2014 Feb; 89():28-33. PubMed ID: 24252722
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
7. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
8. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS studies of ritonavir and its forced degradation products.
Rao RN; Ramachandra B; Vali RM; Raju SS
J Pharm Biomed Anal; 2010 Dec; 53(4):833-42. PubMed ID: 20619992
[TBL] [Abstract][Full Text] [Related]
10. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
11. Study of forced degradation behaviour of florfenicol by LC and LC-MS and development of a validated stability-indicating assay method.
Mistiri F; Louati K; Grissa O; Kallel M; Safta F
Ann Pharm Fr; 2012 Nov; 70(6):333-47. PubMed ID: 23177560
[TBL] [Abstract][Full Text] [Related]
12. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
Salunke N; Kharkar PS; Pandita N
Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
14. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
[TBL] [Abstract][Full Text] [Related]
15. Stability-indicating assay method for determination of actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathways
Abiramasundari A; Joshi RP; Jalani HB; Sharma JA; Pandya DH; Pandya AN; Sudarsanam V; Vasu KK
J Pharm Anal; 2014 Dec; 4(6):374-383. PubMed ID: 29403903
[TBL] [Abstract][Full Text] [Related]
16. Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation.
Karthik Y; Babu B; Meyyanathan SN
Sci Pharm; 2015; 83(2):311-20. PubMed ID: 26839817
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
18. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
Rao RN; Vali RM; Raju SS
J Pharm Biomed Anal; 2013 Feb; 74():101-10. PubMed ID: 23245240
[TBL] [Abstract][Full Text] [Related]
20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
